Gelonghui, April 7, 丨 Yingtai Medical (01501.HK) announced that on April 7, 2024, the company submitted listing guidance and filing application materials to the Shanghai Regulatory Bureau of the China Securities Regulatory Commission.
Due to business development needs, the company plans to prepare for listing on stock exchanges in China (“Recommended A-share listing”). The advising agency for A-share listing is China International Finance Co., Ltd. The proposed A-share listing is still in the early planning stage. As of the announcement date, the company has not submitted any formal listing application to any relevant regulatory authority in China.